Switching Stable Kidney Transplant Recipients to a Generic Tacrolimus Is Feasible and Safe, but It Must Be Monitored

Journal of Transplantation
doi 10.1155/2017/5646858
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Genotype-Guided Tacrolimus Dosing in African-American Kidney Transplant Recipients

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2015English

Short-Term Outcomes in Heart Transplant Recipients Treated With Generic Tacrolimus Compared to Prograf

Open Journal of Organ Transplant Surgery
2013English

How Safe Is Conversion From Tacrolimus to Its Generic Drug?—A Single Center Experience

Open Journal of Nephrology
2012English

Antibiotic Resistance Must Be Monitored, US Senate Is Told

Nature
Multidisciplinary
2000English

Evaluation of Allergy to Tacrolimus in Kidney Transplant Candidates and Recipients With a History of Macrolide Antibiotic Allergy

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2018English

It Must Be

Indialogs
2016English

532 Switching From Calcineurin Inhibitors to Belatacept Decreases Keratinocyte Carcinomas Incidence Rate in Kidney Transplant Recipients

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Nonoperative Management of Splenic Injury in Closely Monitored Patients With Reduced Consciousness Is Safe and Feasible

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
Critical CareEmergency MedicineIntensive Care Medicine
2019English

Haemodynamics of Stable Renal Transplant Recipients

Clinical Science
1980English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy